References
- Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2009). Available at: http://www.goldcopd.com/download.asp?intId=554 [Last accessed May 31, 2010]
- American Lung Association. Lung Disease Data: 2008. Available at: http://www.lungusa.org/assets/documents/publications/lung-disease-data/LDD_2008.pdf [Last accessed May 31, 2010]
- O’Donnell DE, Hernandez P, Kaplan A. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary care. Can Respir J 2008;15:1A-8A
- American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality 2010. Available at: http://www.lungusa.org/finding-cures/for-professionals/epidemiology-and-statistics-rpts/copd-trend-report.pdf [Last accessed April 6, 2010]
- Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000;117:1S-4S
- Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:741-50
- Van Noord JA, Aumann JL, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006;129:509-17
- van der Palen J, Klein JJ, van Herwaarden CL, et al. Multiple inhalers confuse asthma patients. Eur Respir J 1999;14:1034-7
- Broeders MEAC, Molema J, Hop WC, et al. Inhalation profiles in asthmatic and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003;16:131-41
- Lavorini F, Levy ML, Corrigan C, Crompton G; The ADMIT Working Group. The ADMIT Series - issues in inhalation therapy. (6) Training tools for inhalation devices. Prim Care Respir J 2010;19:335-341
- Mahesh PA, Vedanthan PK, Amrutha DH, et al. Factors associated with non-adherence to specific allergen immunotherapy in management of respiratory allergy. Indian J Chest Dis Allied Sci 2010;52:91-5
- Cummings KM, Becker MH, Kirscht JP, et al. Psychosocial factors affecting adherence to medical regiments in a group of hemodialysis patients. Med Care 1982;20:567-80
- Chrischilles E, Gilden D, Kubisiak J, et al. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am J Manag Care 2002;8:902-11
- George J, Kong DC, Thoman R, et al. Factors associated with medication nonadherence in patients with COPD. Chest 2005;128:3198-204
- World Health Organization. Adherence to long-term therapies: policy for action. Available at: http://www.who.int/chronic_conditions/adherence/en/ [Last accessed on April 6, 2010]
- Han MK. Medication adherence in COPD: what have we learned?. Thorax 2009;64:922-3
- Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63:831-8
- Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64:939-43
- Haupt D, Krigsman K, Nilsson JLG. Medication persistence among patients with asthma/COPD drugs. Pharm World Sci 2008;30:509-14
- Rand CS. Patient adherence with COPD therapy. Eur Respir Rev 2005;14:97-101
- Tashkin DP. Multiple dose regimens: Impact on compliance. Chest 1995;107:176-82S
- Yu F, Doucette P. Select matched-pair control sampling using PROC SURVEYSELECT. SAS Online Documentation, version 9.1 SAS/STAT User’s Guide, SAS Institute, Cary, NC, USA
- Yu AP, Yang H, Wu EQ. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis. J Med Econ 2011; [Epub ahead of print]
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
- Frith PA, Cafarella PA, Duffy JM. Chronic obstructive pulmonary disease (COPD) is a major personal and public health burden in Australia. Aust N Z J Public Health 2008;32:139-41
- Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008;121:789-96
- Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099-107
- Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med 2004;98:351-6
- Breekveltdt-Postma NS, Koerselman J, Erkens JA, et al. Treatment with inhaled corticosteroids in Asthma is too often discontinued. Pharmacoepidemiol Drug Saf 2008;17:411-22
- Cramer AJ, Bradley-Kennedy C, Scalera A. Treatment persistence and compliance with medications for chronic obstructive pulmonary disease. Can Respir J 2007;14:25-9
- Fromer L, Goodwin E, Walsh J. Customizing inhaled therapy to meet the needs of COPD patients. Postgrad Med 2010;122:83-93